v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Feb. 03, 2024   545,973,529      
Balance at beginning of period at Feb. 03, 2024 $ 915,147 $ 32 $ 2,368,597 $ 1,616 $ (1,455,098)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   4,531,330      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   300,299      
Issuance of common stock in connection with equity compensation plans 808   808    
Stock-based compensation expense 65,808   65,808    
Other comprehensive income (loss) (1,587)     (1,587)  
Net loss (56,289)       (56,289)
Balance at end of period (in shares) at May. 04, 2024   550,805,158      
Balance at end of period at May. 04, 2024 923,888 $ 33 2,435,213 29 (1,511,387)
Balance at beginning of period (in shares) at Feb. 01, 2025   565,719,239      
Balance at beginning of period at Feb. 01, 2025 1,069,196 $ 35 2,680,012 (846) (1,610,005)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   3,586,842      
Issuance of common stock in connection with equity compensation plans (in shares)   29,869      
Issuance of common stock in connection with equity compensation plans 22   22    
Stock-based compensation expense 78,958   78,958    
Other comprehensive income (loss) 1,519     1,519  
Net loss (22,121)       (22,121)
Balance at end of period (in shares) at May. 03, 2025   569,335,950      
Balance at end of period at May. 03, 2025 $ 1,127,574 $ 35 $ 2,758,992 $ 673 $ (1,632,126)